Anticoagulation control in Malaysia: Reports of time in therapeutic range, bleeding, and thromboembolic complications

被引：0
|
作者：
Mazlan-Kepli, W. [1 ]
Mohamed, S. [2 ]
Nik-Ismail, N. A. [3 ]
Nagarajah, J. R. [4 ]
机构：
[1] Univ Malaya, Dept Clin Pharm & Pharm Practice, Fac Pharm, Kuala Lumpur 50603, Malaysia
[2] Minist Hlth Malaysia, Hosp Serdang, Dept Pharm, Jalan Puchong, Kajang 43000, Selangor, Malaysia
[3] Minist Hlth Malaysia, Hosp Raja Perempuan Zainab II, Dept Pharm, Jalan Hosp, Kota Baharu 15200, Kelantan, Malaysia
[4] Minist Hlth Malaysia, Hosp Kuala Lumpur, Dept Pharm, Jalan Pahang, Kuala Lumpur 50586, Wilayah Perseku, Malaysia
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2022年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [11] Time in therapeutic range and complications of antithrombotic treatment
    Radovic, Pavica
    Kovacev, Jelena
    Novakovic-Anucin, Sladjana
    Gnip, Sanja
    Canak, Visnja
    Mitic, Gorana
    THROMBOSIS RESEARCH, 2012, 130 : S175 - S175
  • [12] Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in children
    Biss, T. T.
    Avery, P. J.
    Walsh, P. M.
    Kamali, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (05) : 1090 - 1092
  • [13] Does An Alternative Anticoagulation Strategy For LVAD Patients Who Have Had Complications Improve Time-in-therapeutic Range?
    Meece, Lauren
    Al-Ani, Mohammad
    Parker, Alex
    Vilaro, Juan
    Aranda, Juan
    Ahmed, Mustafa M.
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 614 - 614
  • [14] Review of time in therapeutic range of warfarin in a tertiary centre in Malaysia
    Gan, K. X.
    Chung, B. K.
    Sim, K. Y.
    Tan, J. E.
    Lian, Z. Y.
    Chan, E. Z.
    Ling, H. S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 26 - 26
  • [15] RELATIONSHIP OF TIME IN THERAPEUTIC RANGE (TTR) WITH BLEEDING AND STROKE INCIDENCES OF WARFARINISED PATIENTS WITH PULMONARY EMBOLISM IN A TERTIARY HOSPITAL IN MALAYSIA
    Sudirman, N.
    Shaharuddin, S.
    Long, C. M.
    Hashim, R.
    Zulkifly, H. H.
    Kasim, S. S.
    Lim, C. W.
    VALUE IN HEALTH, 2015, 18 (07) : A378 - A378
  • [16] Triple Antithrombotic Therapy Is the Independent Predictor for the Occurrence of Major Bleeding Complications Analysis of Percent Time in Therapeutic Range
    Naruse, Yoshihisa
    Sato, Akira
    Hoshi, Tomoya
    Takeyasu, Noriyuki
    Kakefuda, Yuki
    Ishibashi, Mayu
    Misaki, Masako
    Abe, Daisuke
    Aonuma, Kazutaka
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (04) : 444 - 451
  • [17] Thromboembolic complications in adults with longstanding Fontan circulation: time course, risk factors and role of anticoagulation
    Westhoff-Bleck, M.
    Tutarel, O.
    Bleicher, J.
    Sarikouch, S.
    Zwadlo, C.
    Wessel, A.
    Schieffer, B.
    Breymann, T.
    Meyer, G. P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 190 - 190
  • [18] Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in children: a rebuttal
    Jones, S.
    Monagle, P.
    Newall, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) : 2331 - 2332
  • [19] Effects of anticoagulation provider continuity on time in therapeutic range for warfarin patients
    Bishop, Martin A.
    Streiff, Michael B.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 42 (02) : 283 - 287
  • [20] Effects of anticoagulation provider continuity on time in therapeutic range for warfarin patients
    Martin A. Bishop
    Michael B. Streiff
    Journal of Thrombosis and Thrombolysis, 2016, 42 : 283 - 287
12345